This important study describes a first-in-human trial of autologous p63+ stem cells in patients with idiopathic pulmonary fibrosis, a lethal condition for which effective treatments are lacking. The ...
The Global Autologous Cell Therapy Market has seen significant growth and is expected to continue expanding with a projected CAGR of 18.1% from 2019 to 2027, reaching a market value of approximately ...
Autologous stem cell transplant plus Rituxan did not improve survival outcomes in certain patients with mantle cell lymphoma compared with Rituxan alone.